Ionis Pharmaceuticals (IONS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2023 | 06-2023 | 03-2023 | 12-2022 | 09-2022 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 352,060 | 424,790 | 309,031 | 276,472 | 314,993 |
| Marketable Securities | 1,883,522 | 1,960,598 | 2,037,750 | 1,710,397 | 1,666,670 |
| Receivables | 142,359 | 27,956 | 13,914 | 25,538 | 6,645 |
| Inventories | 25,634 | 25,538 | 22,200 | 22,033 | 20,645 |
| Other current assets | 181,075 | 177,872 | 159,724 | 168,254 | 143,173 |
| TOTAL | $2,584,650 | $2,616,754 | $2,542,619 | $2,202,694 | $2,152,126 |
| Non-Current Assets | |||||
| PPE Net | 70,928 | 91,634 | 85,158 | 74,294 | 180,806 |
| Intangibles | 0 | 0 | 0 | 0 | 29,605 |
| Other Non-Current Assets | 278,393 | 262,743 | 257,444 | 256,888 | 59,434 |
| TOTAL | $349,321 | $354,377 | $342,602 | $331,182 | $269,845 |
| Total Assets | $2,933,971 | $2,971,131 | $2,885,221 | $2,533,876 | $2,421,971 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | N/A | 8,239 | N/A | 4,970 |
| Accounts payable and accrued liabilities | 5,615 | 24,021 | 10,499 | 17,921 | 20,545 |
| Accrued Expenses | 152,749 | 134,067 | 130,862 | 189,279 | 158,412 |
| Other current liabilities | 9,952 | 8,903 | N/A | 7,535 | N/A |
| TOTAL | $404,210 | $287,975 | $259,221 | $311,561 | $283,454 |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | 16,436 | N/A | 15,973 | 25,107 |
| Deferred Revenues | 204,824 | 96,252 | 92,335 | 90,577 | 99,511 |
| Other Non-Current Liabilities | 1,965,029 | 1,984,021 | 1,866,457 | 1,345,687 | 1,224,393 |
| TOTAL | $2,214,301 | $2,254,855 | $2,139,430 | $1,649,428 | $1,544,156 |
| Total Liabilities | $2,618,511 | $2,542,830 | $2,398,651 | $1,960,989 | $1,827,610 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 143,472 | 143,326 | 143,092 | 142,954 | 142,050 |
| Common Shares | 143 | 143 | 143 | 142 | 142 |
| Retained earnings | -1,786,648 | -1,639,238 | -1,553,948 | -1,429,625 | -1,377,195 |
| Other shareholders' equity | -46,037 | -50,913 | -48,983 | -57,480 | -63,140 |
| TOTAL | $315,460 | $428,301 | $486,570 | $572,887 | $594,361 |
| Total Liabilities And Equity | $2,933,971 | $2,971,131 | $2,885,221 | $2,533,876 | $2,421,971 |